0

Talsaclidine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP147025534
CAS147025-53-4
Structure
Molecular Weight165.23
InChI KeyXVFJONKUSLSKSW-JTQLQIEISA-N
Description≥98% (HPLC), oil
SolubilityDMSO: >5 mg/mL
Assay≥98% (HPLC)
Formoil
Size10MG, 25MG
Storage Conditions−20°C
1

Central Activation of the Sympathetic Nervous System Including the Adrenals in Anaesthetized Guinea Pigs by the Muscarinic Agonist Talsaclidine

A Walland, M P Pieper

Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):426-30.

PMID: 9606029

1

Compensation of Muscarinic Bronchial Effects of Talsaclidine by Concomitant Sympathetic Activation in Guinea Pigs

A Walland, R Palluk, S Burkard, R Hammer

Eur J Pharmacol. 1997 Jul 9;330(2-3):213-9.

PMID: 9253956

1

Features and Outcomes of Drugs for Combination Therapy as Multi-Targets Strategy to Combat Alzheimer's Disease

Atish Kumar Sahoo, Jagnehswar Dandapat, Umesh Chandra Dash, Satish Kanhar

J Ethnopharmacol. 2018 Apr 6;215:42-73.

PMID: 29248451

1

Memory-related Task Performance by Aged Rhesus Monkeys Administered the Muscarinic M(1)-preferring Agonist, Talsaclidine

Alvin V Terry Jr, Jerry J Buccafusco, Franco Borsini, Andreas Leusch

Psychopharmacology (Berl). 2002 Jul;162(3):292-300.

PMID: 12122487

1

Treatment With the Selective Muscarinic m1 Agonist Talsaclidine Decreases Cerebrospinal Fluid Levels of A Beta 42 in Patients With Alzheimer's Disease

Christoph Hock, Alessia Maddalena, Andreas Raschig, Franz Müller-Spahn, Gerhard Eschweiler, Klaus Hager, Isabella Heuser, Harald Hampel, Thomas Müller-Thomsen, Wolfgang Oertel, Marion Wienrich, Andri Signorell, etc.

Amyloid. 2003 Mar;10(1):1-6.

PMID: 12762134

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode